The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation information

Oral Presentation

(E) Pharmaceutical Health Care and Sciences

[27H-pm] Clinical trials/Risk management/Others

Sun. Mar 27, 2022 3:54 PM - 5:18 PM [Room H] Conference Room 221 (Bldg. 2: 2F)

Chair: Shinji Hidaka

3:54 PM - 4:06 PM

[27H-pm12] Systematic review of adverse events for combination therapy of multi-tyrosine kinase inhibitor and immunotherapy.

○Takashi Sawada1, Mamoru Narukawa1 (1. Department of Clinical Medicine (Pharmaceutical Medicine), Graduate School of Pharmaceutical Sciences, Kitasato University.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password